Adenosine vs. Diltiazem

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

Also called NCT07456423

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 140 participants (enrolled count) (from the registry)
Sponsor
Haseki Training and Research Hospital (from the registry)
Registry
  • NCT NCT07456423
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Türkiye (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07456423. Randomized; single masking; primary purpose treatment. Start 2024-07-01 (actual); primary completion 2025-06-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Adenosine vs. Diltiazem
Acronym
AVNRTstdy
Condition
Supraventricular Tachycardia (SVT)
Condition
Atrioventricular Nodal Re Entrant Tachycardia
Intervention (Drug)
Adenosine intravenous
Intervention (Drug)
Diltiazem intravenous
Lead sponsor
Haseki Training and Research Hospital (class: other)

Record details

Record id
cardio:ct-nct07456423
Content hash
351395e41e59f2a465aa7b710f20fdc7aa79e5a6440c1a22b867f67cc2b68ed0